Cytokinetics Incorporated News

Latest updates and market news for CYTK

4 news

Feb 19 - Feb 25, 2026

Page 1

MT Newswires

5 days ago

RBC Raises Price Target on Cytokinetics to $101 From $95, Keeps Outperform, Speculative Risk

📈

AI Sentiment

Highly Positive

8/10

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 days ago

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

➖

AI Sentiment

Neutral

4/10

Cytokinetics, Incorporated (CYTK) Poised for Market Share Gain with Myqorzo in Cardiac Myosin Space

Insider Monkey

5 days ago

Cytokinetics, Incorporated (CYTK) Poised for Market Share Gain with Myqorzo in Cardiac Myosin Space

📈

AI Sentiment

Highly Positive

9/10

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

6 days ago

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

📈

AI Sentiment

Highly Positive

9/10

Share this news page

Share on Social Networks: